Search

Your search keyword '"Fountain NB"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Fountain NB" Remove constraint Author: "Fountain NB"
102 results on '"Fountain NB"'

Search Results

1. Association of ultra-rare coding variants with genetic generalized epilepsy: A case–control whole exome sequencing study

2. Quantitative analysis of phenotypic elements augments traditional electroclinical classification of common familial epilepsies

Catalog

Books, media, physical & digital resources

3. Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy

4. De novo mutations in epileptic encephalopathies

6. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.

9. Common conditions, part 6. Migraine, epilepsy, MS.

11. Preclinical toxicity studies supporting 2DG for treatment of status epilepticus.

12. Associations Between Testing and Treatment Pathways in a Case of Pediatric Nonlesional Epilepsy: A Census Survey of NAEC Center Directors.

13. Developing optimized physical activity interventions for drug-resistant epilepsy: Challenges and lessons learned from a remote exercise intervention pilot trial.

14. Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray.

15. Epilepsy monitoring unit practices and safety among NAEC epilepsy centers: A census survey.

16. A single-center survey on physical activity barriers, behaviors and preferences in adults with epilepsy.

17. Time-to-event clinical trial designs: Existing evidence and remaining concerns.

18. Multifocal hypometabolic correlates to deficits of verbal memory in mesial temporal lobe epilepsy.

19. Associations between testing and treatment pathways in lesional temporal or extratemporal epilepsy: A census survey of NAEC center directors.

20. 2DG and glycolysis as therapeutic targets for status epilepticus.

21. Association Between Characteristics of National Association of Epilepsy Centers and Reported Utilization of Specific Surgical Techniques.

22. Epilepsy center characteristics and geographic region influence presurgical testing in the United States.

23. Competency-based EEG education: a list of "must-know" EEG findings for adult and child neurology residents

24. Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States.

25. United States Epilepsy Center Characteristics: A Data Analysis From the National Association of Epilepsy Centers.

26. A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children.

27. Dynamic FDG-PET in localization of focal epilepsy: A pilot study.

28. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.

29. Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial.

30. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy.

31. The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus.

32. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.

33. Electrocorticographic events from long-term ambulatory brain recordings can potentially supplement seizure diaries.

34. Incidence of seizure exacerbation and injury related to football participation in people with epilepsy.

36. Direct and indirect costs associated with stereotactic radiosurgery or open surgery for medial temporal lobe epilepsy: Results from the ROSE trial.

37. Visual field defects after radiosurgery versus temporal lobectomy for mesial temporal lobe epilepsy: Findings of the ROSE trial.

38. Radiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trial.

39. Sudden unexpected death in epilepsy in patients treated with brain-responsive neurostimulation.

40. Indications and methodology for video-electroencephalographic studies in the epilepsy monitoring unit.

41. Earlier seizure onset and longer epilepsy duration correlate with the degree of temporal hypometabolism in patients with mesial temporal lobe sclerosis.

42. Reducing placebo exposure in trials: Considerations from the Research Roundtable in Epilepsy.

43. Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy.

44. Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas.

46. Circadian and ultradian patterns of epileptiform discharges differ by seizure-onset location during long-term ambulatory intracranial monitoring.

47. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.

48. Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography.

49. Interrater reliability in interpretation of electrocorticographic seizure detections of the responsive neurostimulator.